Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR

Journal of Clinical Microbiology

Volumn 47, Issue 3, 2009, Pages 521-526

  Jiang, Mingjun ^a   Baseman, Janet G ^b   Koutsky, Laura A ^b   Feng, Qinghua ^a   Mao, Constance ^a   Kiviat, Nancy B ^a   Xi, Long Fu ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MALE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS STRAIN;

BASE PAIR MISMATCH; CERVIX UTERI; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PLASMIDS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS INTEGRATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 62749111532     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02115-08     Document Type: Article

References (34)

1. Alazawi, W., M. Pett, B. Arch, L. Scott, T. Freeman, M. A. Stanley, and N. Coleman. 2002. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res. 62:6959-6965.
2. Andersson, S., H. Safari, M. Mints, I. Lewensohn-Fuchs, U. Gyllensten, and B. Johansson. 2005. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br. J. Cancer 92:2195-2200.
3. Arias-Pulido, H., C. L. Peyton, N. E. Joste, H. Vargas, and C. M. Wheeler. 2006. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J. Clin. Microbiol. 44:1755-1762.
4. Azizi, N., J. Brazete, C. Hankins, D. Money, J. Fontaine, A. Koushik, A. Rachlis, K. Pourreaux, A. Ferenczy, E. Franco, and F. Coutlee. 2008. Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia. J. Gen. Virol. 89:1716-1728.
5. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
6. Briolat, J., V. Dalstein, M. Saunier, K. Joseph, S. Caudroy, J. L. Pretet, P. Birembaut, and C. Clavel. 2007. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int. J. Cancer 121:2198-2204.
7. Castellsague, X., F. X. Bosch, and N. Munoz. 2002. Environmental co-factors in HPV carcinogenesis. Virus Res. 89:191-199.
8. Chan, S. Y., L. Ho, C. K. Ong, V. Chow, B. Drescher, M. Durst, J. ter Meulen, L. Villa, J. Luande, H. N. Mgaya, et al. 1992. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J. Virol. 66:2057-2066.
9. Cheung, J. L., K. W. Lo, T. H. Cheung, J. W. Tang, and P. K. Chan. 2006. Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia. J. Infect. Dis. 194:1706-1712.
10. Cricca, M., A. M. Morselli-Labate, S. Venturoli, S. Ambretti, G. A. Gentilomi, G. Gallinella, S. Costa, M. Musiani, and M. Zerbini. 2007. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Gynecol. Oncol. 106:549-557.
11. De Marco, L., A. Gillio-Tos, L. Bonello, V. Ghisetti, G. Ronco, and F. Merletti. 2007. Detection of human papillomavirus type 16 integration in pre-neoplastic cervical lesions and confirmation by DIPS-PCR and sequencing. J. Clin. Virol. 38:7-13.
12. Fink, L., W. Seeger, L. Ermert, J. Hanze, U. Stahl, F. Grimminger, W. Kummer, and R. M. Bohle. 1998. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat. Med. 4:1329-1333.
13. Fujii, T., N. Masumoto, M. Saito, N. Hirao, S. Niimi, M. Mukai, A. Ono, S. Hayashi, K. Kubushiro, E. Sakai, K. Tsukazaki, and S. Nozawa. 2005. Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia. Diagn. Mol. Pathol. 14:103-108.
14. Guo, M., N. Sneige, E. G. Silva, Y. J. Jan, D. E. Cogdell, E. Lin, R. Luthra, and W. Zhang. 2007. Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod. Pathol. 20:256-266.
15. Jeon, S., B. L. Allen-Hoffmann, and P. F. Lambert. 1995. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69:2989-2997.
16. Jeon, S., and P. F. Lambert. 1995. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA 92:1654-1658.
17. Kulasingam, S. L., J. P. Hughes, N. B. Kiviat, C. Mao, N. S. Weiss, J. M. Kuypers, and L. A. Koutsky. 2002. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 288:1749-1757.
18. Kulmala, S. M., S. M. Syrjanen, U. B. Gyllensten, I. P. Shabalova, N. Petrovichev, P. Tosi, K. J. Syrjanen, and B. C. Johansson. 2006. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J. Clin. Pathol. 59:513-517.
19. Meissner, J. 1997. Sequencing errors in reference HPV clones, p. 110-123. In G. Myers, C. Baker, K. Munger, et al. (ed.), Human papillomavirus 1997: a compilation and analysis of nucleic acid and amino acid sequences, 3rd ed. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM.
20. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
21. Nagao, S., M. Yoshinouchi, Y. Miyagi, A. Hongo, J. Kodama, S. Itoh, and T. Kudo. 2002. Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J. Clin. Microbiol. 40:863-867.
22. Peitsaro, P., B. Johansson, and S. Syrjanen. 2002. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J. Clin. Microbiol. 40:886-891.
23. Pett, M., and N. Coleman. 2007. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J. Pathol. 212:356-367.
24. Pett, M. R., W. O. Alazawi, I. Roberts, S. Dowen, D. I. Smith, M. A. Stanley, and N. Coleman. 2004. Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res. 64:1359-1368.
25. Romanczuk, H., and P. M. Howley. 1992. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc. Natl. Acad. Sci. USA 89:3159-3163.
26. Rousseau, M. N., V. Costes, I. Konate, N. Nagot, V. Foulongne, A. Ouedraogo, P. Van de Perre, P. Mayaud, and M. Segondy. 2007. Viral load and genomic integration of HPV 16 in cervical samples from HIV-1-infected and uninfected women in Burkina Faso. J. Med. Virol. 79:766-770.
27. Seedorf, K., G. Krammer, M. Durst, S. Suhai, and W. G. Rowekamp. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
28. Si, H. X., S. W. Tsao, C. S. Poon, Y. C. Wong, and A. L. Cheung. 2005. Physical status of HPV-16 in esophageal squamous cell carcinoma. J. Clin. Virol. 32:19-23.
29. Tonon, S. A., M. A. Picconi, P. D. Bos, J. B. Zinovich, J. Galuppo, L. V. Alonio, and A. R. Teyssie. 2001. Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions. J. Clin. Virol. 21:129-134.
30. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
31. Wang, S. S., and A. Hildesheim. 2003. Viral and host factors in human papillomavirus persistence and progression, p. 35-40. In Journal of the National Cancer Institute monographs, no. 31. National Cancer Institute, Bethesda, MD.
32. Whiley, D. M., and T. P. Sloots. 2005. Sequence variation in primer targets affects the accuracy of viral quantitative PCR. J. Clin. Virol. 34:104-107.
33. Yamada, T., M. M. Manos, J. Peto, C. E. Greer, N. Munoz, F. X. Bosch, and C. M. Wheeler. 1997. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 71:2463-2472.
34. Yoshida, T., T. Sano, T. Kanuma, N. Owada, S. Sakurai, T. Fukuda, and T. Nakajima. 2008. Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions. Int. J. Gynecol. Cancer 18:121-127.